Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer's disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 589-593

  Habert, Marie Odile ^a,b   De Souza, Leonardo Cruz ^b   Lamari, Foudil ^b   Daragon, Nelle ^b   Desarnaud, Serge ^b   Jardel, Claude ^b   Dubois, Bruno ^b   Sarazin, Marie ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alzheimer's disease; CSF biomarkers; Mild cognitive impairment; RCBF; SPECT

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CYSTEINE ETHYL ESTER TC 99M; PHOSPHOPROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HUMAN; LEFT HEMISPHERE; LUMBAR PUNCTURE; MALE; MILD COGNITIVE IMPAIRMENT; PARIETAL LOBE; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PERFUSION IMAGING; SOFTWARE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77949272180     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1285-8     Document Type: Article

References (15)

1. K Blennow H Hampel 2003 CSF markers for incipient Alzheimer's disease Lancet Neurol 2 10 605 613 10.1016/S1474-4422(03)00530-1 1:CAS:528: DC%2BD3sXotlGhsbg%3D 14505582 (Pubitemid 37162569)
2. JW Ashford WJ Shih J Coupal R Shetty A Schneider C Cool, et al. 2000 Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease J Nucl Med 41 1 57 64 1:STN:280:DC%2BD3c7ht1Wgsw%3D%3D 10647605
3. KM Bradley VT O'Sullivan ND Soper Z Nagy EM King AD Smith, et al. 2002 Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease Brain 125 Pt 8 1772 1781 10.1093/brain/awf185 1:STN:280: DC%2BD38zoslWqtw%3D%3D 12135968
4. M Tsolaki V Sakka G Gerasimou N Dimacopoulos O Chatzizisi KN Fountoulakis, et al. 2001 Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects Am J Alzheimers Dis Other Demen 16 1 21 31 10.1177/153331750101600107 1:STN:280:DC%2BD3Mzltlyqsw%3D%3D 11416945
5. R Ceravolo D Borghetti L Kiferle G Tognoni A Giorgetti D Neglia, et al. 2008 CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease Brain Res Bull 76 1-2 80 84 10.1016/j.brainresbull.2008.01.010 1:CAS:528:DC%2BD1cXktlGhsLs%3D 18395614
6. C Haense K Buerger E Kalbe A Drzezga SJ Teipel P Markiewicz, et al. 2008 CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease Eur J Neurol 15 11 1155 1162 10.1111/j.1468-1331.2008.02274.x 1:STN:280:DC%2BD1cjgslCmsQ%3D%3D 18803648
7. S Arlt S Brassen H Jahn F Wilke M Eichenlaub I Apostolova, et al. 2009 Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease Eur J Nucl Med Mol Imaging 36 7 1090 1100 10.1007/s00259-009-1063-7 1:CAS:528:DC%2BD1MXmvV2rurw%3D 19219430
8. R Vukovich R Perneczky A Drzezga H Förstl A Kurz M Riemenschneider 2009 Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease Dement Geriatr Cogn Disord 27 5 474 480 10.1159/000218080 1:CAS:528:DC%2BD1MXmslCnurg%3D 19439965
9. B Dubois HH Feldman C Jacova ST Dekosky P Barberger-Gateau J Cummings, et al. 2007 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 8 734 746 10.1016/S1474-4422(07)70178- 3 17616482 (Pubitemid 47058377)
10. T Tapiola I Alafuzoff SK Herukka L Parkkinen P Hartikainen H Soininen, et al. 2009 Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain Arch Neurol 66 3 382 389 10.1001/archneurol.2008.596 19273758
11. EC Petrie DJ Cross D Galasko GD Schellenberg MA Raskind ER Peskind, et al. 2009 Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings Arch Neurol 66 5 632 637 10.1001/archneurol.2009.59 19433663
12. D de Jong RW Jansen YA Pijnenburg WJ van Geel GF Borm HP Kremer, et al. 2007 CSF neurofilament proteins in the differential diagnosis of dementia J Neurol Neurosurg Psychiatry 78 9 936 938 10.1136/jnnp.2006.107326 17314187 (Pubitemid 47310827)
13. H Engler A Forsberg O Almkvist G Blomquist E Larsson I Savitcheva, et al. 2006 Two-year follow-up of amyloid deposition in patients with Alzheimer's disease Brain 129 Pt 11 2856 2866 10.1093/brain/awl178 16854944 (Pubitemid 44684508)
14. C Andersson K Blennow O Almkvist N Andreasen P Engfeldt SE Johansson, et al. 2008 Increasing CSF phospho-tau levels during cognitive decline and progression to dementia Neurobiol Aging 29 10 1466 1473 10.1016/j. neurobiolaging.2007.03.027 1:CAS:528:DC%2BD1cXhtVSjsr%2FK 17512092
15. N Tzourio-Mazoyer B Landeau D Papathanassiou F Crivello O Etard N Delcroix, et al. 2002 Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain Neuroimage 15 1 273 289 10.1006/nimg.2001.0978 1:STN:280: DC%2BD38%2FltFCntw%3D%3D 11771995 (Pubitemid 34852226)